A study in the September 4 issue of iJAMA/i reveals that the use of 4 different 13-valent pneumococcal conjugate vaccine immunization schedules in healthy term infants resulted in no statistically significant differences in antibody levels between the infants. "The World Health Organization (WHO) estimated that more than 800,000 children younger than 5 years died from pneumococcal disease in 2000, making it the leading vaccine-preventable cause of death. Since ...You have just read an article categorized health
titled Research Elaborates on Comparison of Antibody Levels for 4 Different Immunization Schedules For PCVs.
Written by:
editor - Thursday, September 5, 2013
There are currently no comments for "Research Elaborates on Comparison of Antibody Levels for 4 Different Immunization Schedules For PCVs"
Post a Comment